600833 第一医药
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)12.4489.14216.6686.5329.340
总资产报酬率 ROA (%)6.8474.5768.5113.6195.247
投入资产回报率 ROIC (%)9.1946.09811.6145.2227.891

边际利润分析
销售毛利率 (%)16.77419.10120.52517.73717.786
营业利润率 (%)16.7995.4387.1782.5134.505
息税前利润/营业总收入 (%)18.2926.1537.1993.3104.672
净利润/营业总收入 (%)14.5234.9075.4053.5344.319

收益指标分析
经营活动净收益/利润总额(%)0.69323.417118.75746.75671.608
价值变动净收益/利润总额(%)5.15620.3082.3132.9762.129
营业外收支净额/利润总额(%)12.04715.791-0.05946.13821.135

偿债能力分析
流动比率 (X)1.6811.6511.5081.4921.472
速动比率 (X)1.1781.1601.1471.0091.111
资产负债率 (%)43.33945.87452.98541.70546.334
带息债务/全部投入资本 (%)12.67314.96428.2555.10217.660
股东权益/带息债务 (%)595.332482.544218.5471,623.254437.043
股东权益/负债合计 (%)129.732117.16788.083138.520114.742
利息保障倍数 (X)-22.649-20.157277.658-2.442-4.487

营运能力分析
应收账款周转天数 (天)48.53447.48525.18234.03328.107
存货周转天数 (天)80.63481.56346.83867.30060.196